These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 8729894

  • 1. Exogenous surfactant use in neonates.
    Ishisaka DY.
    Ann Pharmacother; 1996 Apr; 30(4):389-98. PubMed ID: 8729894
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Calfactant: a review of its use in neonatal respiratory distress syndrome.
    Onrust SV, Dooley M, Goa KL.
    Paediatr Drugs; 1999 Apr; 1(3):219-43. PubMed ID: 10937453
    [Abstract] [Full Text] [Related]

  • 5. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
    Online J Curr Clin Trials; 1992 Nov 10; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
    Halliday HL.
    Drugs; 1996 Feb 10; 51(2):226-37. PubMed ID: 8808165
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F, Sinha S, Gadzinowski J, D'Agostino R, Segal R, Guardia C, Mazela J, Liu G, SELECT and STAR Study Investigators.
    Pediatrics; 2007 Jun 10; 119(6):e1361-70. PubMed ID: 17533176
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
    Modanlou HD, Beharry K, Padilla G, Norris K, Safvati S, Aranda JV.
    J Perinatol; 1997 Jun 10; 17(6):455-60. PubMed ID: 9447532
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Costs and outcomes associated with colfosceril versus beractant for the treatment of neonatal respiratory distress syndrome.
    Wyble L, Santeiro ML.
    Ann Pharmacother; 1997 Jun 10; 31(6):787-8. PubMed ID: 9184726
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant.
    Lancet; 1992 Dec 05; 340(8832):1363-9. PubMed ID: 1360087
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
    Sehgal SS, Ewing CK, Richards T, Taeusch HW.
    J Natl Med Assoc; 1994 Jan 05; 86(1):46-52. PubMed ID: 8151722
    [Abstract] [Full Text] [Related]

  • 20. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
    Bloom BT, Kattwinkel J, Hall RT, Delmore PM, Egan EA, Trout JR, Malloy MH, Brown DR, Holzman IR, Coghill CH, Carlo WA, Pramanik AK, McCaffree MA, Toubas PL, Laudert S, Gratny LL, Weatherstone KB, Seguin JH, Willett LD, Gutcher GR, Mueller DH, Topper WH.
    Pediatrics; 1997 Jul 05; 100(1):31-8. PubMed ID: 9200357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.